CRISPR

Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?

Climate /

On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures that have been extinct for more than 12,000 years made famous by the HBO show Game of Thrones. These white, fluffy animals live on a 2,000-acre preserve in a location so secretive that journalists, including […]

Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation? Read More »

Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths

Biotech & Health /

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation from TWG Global, the investment company of Guggenheim Partners co-founder Mark Walter, and the billionaire Thomas Tull. The funding comes two years after

Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths Read More »